Bovine herpesvirus (BoHV) glycoprotein E (gE) is a non-essential envelope glycoprotein and the deletion of gE has been used to develop BoHV-1 and BoHV-5 differential vaccine strains. The DIVA (Differentiation of Infected from Vaccinated Animals) strategy, using marker vaccines based on gE-negative BoHV strains, allows the identification of vaccinated or infected animals in immunoassays designed to detect anti-gE antibodies. In this study a codon optimized synthetic sequence of gE containing highly conserved regions from BoHV-1 and BoHV-5 was expressed in Pichia pastoris. Following expression, the recombinant gE (rgE) was secreted and purified from the culture medium. The rgE was identified by Western blotting (WB) using sera from cattle naturally infected with BoHV-1 and/or BoHV-5, or sera from bovines experimentally infected with wild-type BoHV-5. Sera collected from cattle vaccinated with a BoHV-5 gI/ gE/US9 marker vaccine failed to recognise rgE. Expression of rgE, based on a sequence containing highly conserved regions from BoHV-1 and BoHV-5, in P. pastoris enabled the production of large quantities of rgE suitable for use in immunoassays for the differentiation vaccinated or infected cattle.
Introduction
Bovine herpesviruses types 1 (BoHV-1) and 5 (BoHV-5) are important pathogens associated with respiratory, reproductive and neurological disorders in cattle [1] , that cause significant economic losses in the beef and dairy industry. Both viruses belong to the Herpesviridae, subfamily Alphaherpesvirinae, genus Varicellovirus [2] . Following a typical herpesvirus pattern, they can establish longterm latent infections in their hosts, with sporadic episodes of viral shedding [3] . BoHV-1 is distributed worldwide [4] while BoHV-5 is restricted to a number of countries in South America including Brazil [5] , Argentina [6] , Colombia [7] and Uruguay [8] . In the northern hemisphere, the occurrence of BoHV-5 infections is rare [9, 10] . Inactivated and modified live vaccines have been used worldwide in an attempt to control herpesvirus infections in cattle [11] , and most of these are based on BoHV-1 strains [12, 13] . Crossprotection against BoHV-1 and BoHV-5 may occur as the proteomes are highly conserved, average 82.0% [14, 15] ; however, this is not always the case [16] . In addition, animals may be infected with both virus types [17] .
Glycoprotein E (gE) is a non-essential glycoprotein which has been used as an antigenic marker for BoHV-1 and BoHV-5 vaccines [18e23]. The DIVA (Differentiation of Infected from Vaccinated Animals) strategy is based on using marker vaccines, where the gE gene has been deleted from the vaccine strain. This allows protection against the disease while enabling identification of vaccinated or infected animals in immunoassays based on the detection of anti-gE antibodies [20, 24] . The ability to differentiate between vaccinated and infected animals is critical for trading restrictions and surveillance in countries that are running control programs for the eradication of BoHV-1 [25] . Furthermore, it is possible to monitor wild-type virus transmission in animal populations and to determine the true prevalence of infection in herds, regions, and countries [20] , since gE seroconversion means infection postvaccination.
In Brazil, BoHV-1 and BoHV-5 gE-deleted marker vaccines have been developed and tested but are not yet commercially available [22,23,26e31] . Marker vaccines (live or inactivated) represent a good choice for disease control as they protect cattle clinically in case of infection and markedly reduce the subsequent shedding of wild-type virus [22, 23, 32] . A recombinant BoHV-5 lacking thymidine kinase and gE genes was evaluated as a live experimental vaccine and conferred protection upon homologous and heterologous (BoHV-1) challenge [22] . Campos and co-workers showed that a BoHV-5 gI/gE/US9 e inactivated marker vaccine was capable of conferring protection against encephalitis when vaccinated cattle were challenged with a large infectious dose of the parental wildtype BoHV-5 [23] . Furthermore, Romera and colleagues developed and evaluated a gE-deleted BoHV-1 marker vaccine strain as an inactivated and a live attenuated vaccine preparation. Both formulations elicited an efficient and protective immune response against challenge with virulent wild-type BoHV-1 [32] . Importantly, once the marker vaccine was administered there was no evidence of horizontal or vertical spread. Importantly, marker and conventional BoHV vaccines can prevent disease but not latent infection. Accordingly, an interesting safety feature that comes from using live attenuated marker vaccines based on gE-deleted viruses is that the virus cannot spread in an anterograde direction from the sensory neurons in the trigeminal ganglia to the respiratory mucosa [32, 33] . The implementation of a DIVA strategy requires diagnostic assays for the detection of anti-gE antibodies. However, commercial gE antibody detection assays are rarely used in Brazil due to the high costs associated with importation, justifying the development of new diagnostic tools. Truncated forms of gE from BoHV-1 have been expressed successfully using Baculovirus-insect systems [34e36], mammalian cells [37] and prokaryotic expression methods [35, 38] . However, as gE contains several antigenic domains, detection of anti-gE antibodies is likely to be enhanced using the whole protein [39, 40] . In addition, the yeast expression system offers several advantages relative to other mammalian expression systems including: high growth rates of P. pastoris that are associated with improved protein yield; reduced costs, the growth medium components (glycerol and methanol, biotin, salts, trace elements) are simple and inexpensive; and as P. pastoris is cultured in media with a relatively low pH and methanol it is less likely to become contaminated [41] . Furthermore, P. pastoris represents an excellent alternative to E. coli, since it possesses the eukaryotic machinery needed for posttranslational modifications for processing signal peptide sequences (both pre and prepro types), folding, disulphide bond formation and O-and N-linked glycosylation. Consequently, many proteins sequestered in inclusion bodies in prokaryote expression systems can be produced as biologically active molecules in P. pastoris [42] . In addition, the expression vector pPICZaB uses the secretion signal sequence from Saccharomyces cerevisiae a-factor prepro-peptide (leader) and consequently, heterologous proteins are secreted into the medium, which serves as a substantial first step purification, since P. pastoris secretes only low levels of endogenous proteins [43] .
In the present study, a synthetic gE gene, containing highly conserved regions from BoHV-1 and BoHV-5 and optimized for yeast codon usage, was designed, cloned and expressed in the methylotrophic yeast P. pastoris. Recombinant gE (rgE) was evaluated by Western blotting (WB) and could differentiate between sera collected from vaccinated and BoHV infected cattle.
Materials and methods

Strains and growth conditions
Escherichia coli DH5a was grown in Luria-Bertani (LB) low-salt medium (1% tryptone, 0.5% yeast extract, 0.5% NaCl -pH 7.5) at 37 C with the addition of zeocin (25 mg/ml). Pichia pastoris strain KM71H (MutS, Invitrogen) was grown in yeast extract peptone dextrose (YPD) medium (1% yeast extract, 2% peptone and 2% Dglucose) supplemented with 100 mg/ml of zeocin at 28 C.
Cloning of the gE gene
Following the alignment of six gE proteins (GenBank accession numbers: NP_045372.1, AAA67214.1, ADE08265.1, AAF71143.1, YP_003662535.1, AAF34744.1) we identified a polypeptide that included highly conserved regions in both BoHV-1 and BoHV-5. This was encoded by a 1682 bp sequence from BoHV-1 and was named BoHV-1/5 gE. The codon usage of the gE sequence was optimized for P. pastoris (based on the codon usage database at http://www.kazusa.or.jp/codon). Restriction enzyme sites for EcoRI and KpnI, at the 5'-and 3'-termini, respectively, were included in the gE sequence for subsequent cloning into the pPICZaB expression vector (Invitrogen, Brazil). The presence of the insert was determined by restriction enzyme digestion with EcoRI and KpnI. The pPICZaB/BoHV-1/5 gE plasmid was propagated in E. coli DH5a, purified (Purelink Quick Mini 50 Kit, Invitrogen, Brazil) and linearized with SacI restriction enzyme (Invitrogen, Brazil). Linear plasmid DNA was purified by phenol-chloroform extraction and DNA precipitation as previously described [44] . P. pastoris competent cells were transformed with 10 mg of linear plasmid DNA by electroporation (25 mF, 200 U, 2 kV).
Animal sera
Sera samples were collected from cattle: naturally infected with BoHV-1 and/or BoHV-5 (n ¼ 10, named S1-S10); experimentally infected with a wild-type BoHV-5 strain (n ¼ 10, named S11-S20) [23]; vaccinated with a BoHV-5 gI/gE/US9 vaccine strain (n ¼ 10, named S21-S30) [28] and a negative control serum sample was collected from a healthy calf (ELISA negative for BoHV antibodies). The sera samples (S1-S10 and the negative control sample) were provided by the Virology Laboratories, Federal University of Pelotas and the Federal University of Rio Grande do Sul (S11-S30), RS, Brazil.
Screening for P. pastoris clones expressing rgE
Recombinant P. pastoris clones (Rcs) were screened for the presence of rgE by colony blotting (150 colonies were tested) and dot blotting (59 recombinant clones were screened by spotting 5 ml of each supernatant sample onto a nitrocellulose membrane), as described previously [44] . The presence of rgE was detected using anti-Histidine mAb (cat. No. H1029, Sigma-Aldrich, Brazil) at a dilution of 1:6.000 in PBST, and pooled serum samples from BoHV infected cattle (1:10.000 in PBST). The anti-Histidine mAb and the cattle sera were pooled prior to incubation with the blots. Using the 10 highest expressing clones, a dot-blot time-course study (24, 72 and 144 h) was performed to determine optimal protein secretion. The relative integrated density of each dot was measured using ImageJ software (version 1.50i, National Institutes of Health, USA).
Expression and purification of rgE in P. pastoris KM71H
The recombinant clone with the highest expression level of rgE was used to inoculate 25 ml of BMGY (2% glycerol) in a baffled flask and was incubated in an orbital shaker at 28 C, 250 rpm, to an OD600 of 2e6. The cells were harvested by centrifugation and resuspended in 100 ml of BMMY to a final OD 600 of 0.5. Expression was induced for 96 h by adding methanol to a final concentration of 0.5% every 24 h, until the culture reached an OD600 of 5, whereupon methanol (1% final concentration) was added every 12 h to maintain expression of rgE, regardless of evaporation and consumption levels. The supernatant containing the secreted rgE was collected by centrifugation and stored at À80 C.
The rgE in the supernatant (100 ml) was purified and concentrated by precipitation with 20% trichloroacetic acid (TCA) as described previously [45, 46] . The protein pellet was resuspended in 1 Â TE (10 mM TriseHCl pH 8.0, 1 mM EDTA, pH 8.0). Samples were suspended in loading buffer (1% SDS, 250 mM Tris pH 6.8, 1% bromophenol blue, 50% glycerol and 1% 2-mercaptoethanol) and boiled for 10 min prior to analysis by 10% SDS-PAGE. The supernatant of untransformed P. pastoris KM71H (20 ml) was precipitated with 20% TCA and used as a negative control. The gel was stained with Coomassie Brilliant Blue R250. The concentration of the purified rgE was determined by Bradford assay (Bio-Rad, USA) using BSA in a standard curve.
Western blotting (WB) to detect gE antibodies
The ability of rgE to be recognized by sera collected from cattle naturally infected, or experimentally infected with BoHV-1 and/or BoHV-5, was evaluated by WB. The rgE was separated by 10% SDS-PAGE (~2 mg/lane) and transferred to a nitrocellulose membrane as described previously [44] . Briefly, 31 membrane strips containing rgE were blocked (PBST, 1% foetal bovine serum), each strip was individually incubated for 1 h at room temperature with the following sera: one of 10 samples (S1-S10) from naturally infected cattle; one of 10 samples (S11-S20) from experimentally infected cattle; one of 10 samples (S21-S30) from cattle vaccinated with a BoHV-5 gI/gE/US9 marker vaccine; and a negative serum sample. Each serum sample was diluted 1:150 in PBST, 1 ml/strip, in a Western blot tray. A wild-type BoHV-5 strain was included as a positive control antigen (10 ml of whole viral extract e concentrated and semi-purified BoHV-5 isolate containing 10 7 TCID 50 /mle 
Results and discussion
Cloning and expression of rgE in P. pastoris
In this study, a gE sequence containing highly conserved regions from BoHV-1 and BoHV-5 was codon optimized and artificially synthesized (see Supplementary data). There are several advantages to using a synthetic codon-optimized gE gene. There is no need to culture the virus, extract DNA, amplify the DNA target by PCR and its subsequent cloning. In addition, the synthetic production of the gene encoding gE allowed the codon-usage to be optimized for P. pastoris. Several authors have explored gene optimization in order to improve protein expression in P. pastoris [47, 48] . Chang et al. [49] obtained a protein expression level 4.6-fold higher using a codon-optimized gene construct when compared to the non-codon optimized production level. Codon optimization has also been shown to reduce protein production time [48, 49] .
After cloning, the pPICZaB/BoHV-1/5 gE plasmid ( Fig. 1 ) was linearized and used to transform P. pastoris KM71H, the resultant clones were screened by colony and dot blotting for the expression of rgE. Of these clones, 59/150 (39.3%) colonies expressed rgE, and of these 59 colonies, 13 (22.0%) recombinant clones were identified as positive by dot blotting, see Fig. 2 . Expression levels of rgE among the recombinant clones varied, even though the colonies were approximately the same size. This was probably due to differences in copy number of the integrated vector, since high copy number integration has been shown to be important for high expression [50] . Of note, the same gE coding sequence expressed and purified from E. coli was not recognized by sera from any of the infected animals (data not shown). Suggesting that post-translational modification of rgE is necessary for recognition by native gE antibodies. A time-course evaluation (at time-points 24, 72 and 144 h) revealed detectable amounts of the recombinant protein after 24 h induction, maximum expression was obtained after 72 h (Rc4, Rc8 and Rc15) and 144 h of induction (Rc14 and Rc16), see Fig. 3 .
The clone with the highest expression levels of rgE (Rc15) was cultured in a glycerol-based medium to generate biomass, followed by cultivation in a medium containing methanol to induce expression of rgE. As the rgE was expressed as a secreted protein there was no need for complex chromatographic purification procedures, rather the rgE was recovered by precipitation using 20% TCA. The total protein yield in the precipitated supernatant of transformed P. pastoris was 140 mg/L.
Following purification and concentration of the supernatant, several (5) secreted proteins were visualized by SDS-PAGE, including a major band (~80 kDa) corresponding to rgE and several unknown proteins (Fig. 4) . The predicted molecular mass (Mm) of rgE was 59.2 kDa while the apparent Mm was~80 kDa. This was not unexpected as previous studies reported gE with an apparent Mm of~94 kDa [52] . This difference was attributed to posttranslational modifications, principally N-glycosylation, the rgE amino acid sequence contained several potential glycosylation sites and disulphide bonds (data not shown). Furthermore, there are reports of rgE with an apparent Mm of~80 kDa when expressed in a Baculovirus-insect system [34, 36] .
Differential diagnosis of infected and vaccinated cattle
All of the sera (10/10) from cattle naturally infected with BoHV-1 and/or BoHV-5 (S1-S10) and from bovines experimentally infected with a BoHV-5 strain (10/10, S11-S20) recognized rgE by WB, see Fig. 5A and B. Furthermore, rgE was not detected by sera (0/10) collected from bovines vaccinated with the BoHV-5 gI/gE/US9 marker vaccine strain (S21-S30) (Fig. 5C) . The presence of antiBoHV antibodies in animals immunised with the marker vaccine was demonstrated using wild-type BoHV-5 virus as a positive control (Cþ), Fig. 5 . The negative control serum (uninfected) did not recognise rgE, see Fig. 5 . Of note, in the Western blots S1-20 ( Fig. 5A  and B) , in addition to the rgE band, an additional band was revealed with an apparent Mm of 160 kDa. This band is possibly a dimer of rgE, since it was recognized by sera from cattle naturally infected with BoHV-1 and/or BoHV-5 and sera from bovines experimentally infected with wild-type BoHV-5.
Conclusion
In the present study, a recombinant gE gene, based on highly conserved regions from BoHV-1 and BoHV-5, was codonoptimized, synthesized and cloned into the P. pastoris expression vector pPICZaB. Following induction, rgE was expressed and Fig. 4 . SDS-PAGE analysis of rgE expression in P. pastoris. Lanes M: Full-Range Rainbow Molecular Weight Marker (GE Healthcare), the apparent Mm (kDa) of each band is indicated; 1: Negative control -supernatant of untransformed P. pastoris KM71H after methanol induction and precipitation with 20% TCA; 2: Purified rgE following precipitation with 20% TCA (16 ml,~2 mg), the apparent mass of~80 kDa is indicated (arrow); 3: Supernatant containing the secreted rgE prior to TCA precipitation. Fig. 5 . WB analysis of rgE expressed in P. pastoris. (A) Lanes S1-S10, rgE (~2 mg/strip) and sera from BoHV-1 and/or BoHV-5 infected cattle; (B) Lanes S11-S20, rgE and sera from cattle experimentally infected with a wild-type BoHV-5 strain; (C) Lanes S21-S30, rgE and sera from cattle immunised with a BoHV-5 gI/gE/US9 marker vaccine; (M) Full-Range Rainbow Molecular Weight Marker (GE Healthcare), the Mm (kDa) of each band is indicated; (C-) rgE and negative control serum (ELISA negative for the presence of BoHV antibodies); (Cþ) Positive control, wild-type BoHV-5 antigen and sera from vaccinated animals. The apparent masses of~80 kDa (rgE) and 160 kDa (possibly a dimer of rgE) are indicated by arrows. secreted into the culture supernatant, which significantly improved protein recovery and purification, compared to gE expression in E. coli. Importantly, rgE retained the antigenic properties of the native protein in WBs, rgE was recognized by sera collected from naturally or experimentally BoHV infected cattle. Of note, rgE was not recognized by sera from cattle vaccinated with a marker vaccine. This suggested that rgE can be used as a diagnostic tool to differentiate between vaccinated and infected cattle. Further studies will focus on optimization of expression of this glycoprotein and its employment as immunodiagnostic reagent in different assay systems.
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